Molecular dynamics study on the influence of C-terminal sugar substitution on dynamics and conformation of vancomycin derivatives

References

• Sheldrick, G.M.; Jones, P.G.; Kennard, O.; Williams, D.H.; Smith, G.A. Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine. Nature 1978, 271, 223–225.
   PubMed Web of Science ®Google Scholar
• Nicolaou, K.C.; Boddy, C.N.C.; Bräse, S.; Winssinger, N. Chemistry, biology, and medicine of the glycopeptide antibiotics. Angew. Chem. Int. Ed. 1999, 38, 2096–2152.
   PubMed Web of Science ®Google Scholar
• Kahne, D.; Leimkuhler, C.; Lu, W.; Walsh, C. Glycopeptide and lipoglycopeptide antibiotics. Chem. Rev. 2005, 105, 425–448.
   PubMed Web of Science ®Google Scholar
• Kern, T.; Giffard, M.; Hediger, S.; Amoroso, A.; Giustini, C.; Bui, N.K.; Joris, B.; Bougault, C.; Vollmer, W.; Simorre, J.-P. Dynamics characterization of fully hydrated bacterial cell walls by solid-state NMR: evidence for cooperative binding of metal ions. J. Am. Chem. Soc. 2010, 132, 10911–10919.
   PubMed Web of Science ®Google Scholar
• Vollmer, W.; Seligman, S.J. Architecture of peptidoglycan: more data and more models. Trends Microbiol. 2010, 18, 59–66.
   PubMed Web of Science ®Google Scholar
• Cabeen, M.T.; Jacobs-Wagner, C. Bacterial cell shape. Nat. Rev. Microbiol. 2005, 3, 601–610.
   PubMed Web of Science ®Google Scholar
• Uttley, A.H.; Collins, C.H.; Naidoo, J.; George, R.C. Vancomycin-resistant enterococci. Lancet 1988, 1, 57–58.
   PubMed Web of Science ®Google Scholar
• Reynolds, P.E.; Courvalin, P. Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine. Antimicrob. Agents Chemother. 2004, 49, 21–25.
   Web of Science ®Google Scholar
• Perichon, B.; Courvalin, P. VanA-type vancomycin-resistant staphylococcus aureus. Antimicrob. Agents Chemother. 2009, 53, 4580–4587.
   PubMed Web of Science ®Google Scholar
• Loll, P.J.; Axelsen, P.H. The structural biology of molecular recognition by vancomycin. Annu. Rev. Biophys. Biomol. Struct. 2000, 29, 265–289.
   PubMedGoogle Scholar
• Ślusarz, R.; Ślusarz, M.J.; Samaszko, J.; Madaj, J. Conformational changes of peptidoglycan fragments during their interactions with vancomycin. Cent. Eur. J. Chem. 2011, 9, 422–431.
   Google Scholar
• Eliopoulos, G.M. Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. J. Infect. 2009, 59 (Suppl 1), S17–S24.
   PubMed Web of Science ®Google Scholar
• Culos, K.A.; Cannon, J.P.; Grim, S.A. Alternative agents to vancomycin for the treatment of methicillin-resistant staphylococcus aureus infections. Am. J. Ther. 2011, 20, 200–212.
   Web of Science ®Google Scholar
• Chang, M.H.; Kish, T.D.; Fung, H.B. Telavancin: a lipoglycopeptide antimicrobial for the treatment of complicated skin and skin structure infections caused by gram-positive bacteria in adults. Clin. Ther. 2010, 32, 2160–2185.
   PubMed Web of Science ®Google Scholar
• Case, D.A.; Darden, T.A.; Cheatham, III, T.E.; Simmerling, C.L.; Wang, J.; Duke, R.E.; Luo, R.; Walker, R.C.; Zhang, W.; Merz, K.M.; et al. AMBER 12. University of California: San Francisco, 2012.
   Google Scholar
• Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M.C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 2003, 24, 1999–2012.
   PubMed Web of Science ®Google Scholar
• Kirschner, K.N.; Yongye, A.B.; Tschampel, S.M.; González-Outeiriño, J.; Daniels, C.R.; Foley, B.L.; Woods, R.J. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J. Comput. Chem. 2008, 29, 622–655.
   PubMed Web of Science ®Google Scholar
• Cieplak, P.; Cornell, W.D.; Bayly, C.; Kollman, P.A. Application of the multimolecule and multiconformational RESP methodology to biopolymers: charge derivation for DNA, RNA, and proteins. J. Comput. Chem. 1995, 16, 1357–1377.
   Web of Science ®Google Scholar
• Snowden, M.A.; Perkins, H.R. Peptidoglycan cross-linking in Staphylococcus aureus. An apparent random polymerisation process. Eur. J. Biochem. 1990, 191, 373–377.
   PubMedGoogle Scholar
• Van Dam, V.; Olrichs, N.; Breukink, E. Specific labeling of peptidoglycan precursors as a tool for bacterial cell wall studies. Chembiochem 2009, 10, 617–624.
   PubMed Web of Science ®Google Scholar
• Williams, D.H.; Bardsley, B. The vancomycin group of antibiotics and the fight against resistant Bacteria. Angew. Chem. Int. Ed. 1999, 38, 1172–1193.
   PubMed Web of Science ®Google Scholar
• Jorgensen, W.L.; Chandrasekhar, J.; Madura, J.D.; Impey, R.W.; Klein, M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926.
   Web of Science ®Google Scholar
• Nitanai, Y.; Kikuchi, T.; Kakoi, K.; Hanamaki, S.; Fujisawa, I.; Aoki, K. Crystal structures of the complexes between vancomycin and cell-wall precursor analogs. J. Mol. Biol. 2009, 385, 1422–1432.
   PubMed Web of Science ®Google Scholar
• Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H.J.C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 1977, 23, 327–341.
   Web of Science ®Google Scholar
• Berendsen, H.J.C.; Postma, J.P.M.; Gunsteren, W.F. van; DiNola, A.; Haak, J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984, 81, 3684–3690.
   Web of Science ®Google Scholar
• Ewald, P.P. Die Berechnung optischer und elektrostatischer Gitterpotentiale. Ann. Phys. 1921, 369, 253–287.
   Google Scholar
• Darden, T.; Perera, L.; Li, L.; Pedersen, L. New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure 1999, 7, R55–R60.
   PubMed Web of Science ®Google Scholar
• Salomon-Ferrer, R.; Götz, A.W.; Poole, D.; Le Grand, S.; Walker, R.C. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. J. Chem. Theory Comput. 2013, 9, 3878–3888.
   PubMed Web of Science ®Google Scholar
• Kollman, P.A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W.; et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res. 2000, 33, 889–897.
   PubMed Web of Science ®Google Scholar
• Reyes, C.M.; Kollman, P.A. Structure and thermodynamics of RNA-protein binding: using molecular dynamics and free energy analyses to calculate the free energies of binding and conformational change. J. Mol. Biol. 2000, 297, 1145–1158.
   PubMed Web of Science ®Google Scholar
• Jayaram, B.; Sprous, D.; Beveridge, D.L. Solvation free energy of biomacromolecules:  parameters for a modified generalized born model consistent with the AMBER force field. J. Phys. Chem. B 1998, 102, 9571–9576.
   Web of Science ®Google Scholar
• De Paris, R.; Quevedo, C.V.; Ruiz, D.D.; Norberto de Souza, O.; Barros, R.C. Clustering molecular dynamics trajectories for optimizing docking experiments. Comput. Intell. Neurosci. 2015, 2015:916240, 1–9.
   Web of Science ®Google Scholar
• Mackay, J.P.; Gerhard, U.; Beauregard, D.A.; Williams, D.H.; Westwell, M.S.; Searle, M.S. Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signaling. J. Am. Chem. Soc. 1994, 116, 4581–4590.
   Web of Science ®Google Scholar
• Sharman, G.J.; Try, A.C.; Dancer, R.J.; Cho, Y.R.; Staroske, T.; Bardsley, B.; Maguire, A.J.; Cooper, M.A.; O'Brie, D.P.; Williams, D.H. The roles of dimerization and membrane anchoring in activity of glycopeptide antibiotics against vancomycin-resistant bacteria. J. Am. Chem. Soc. 1997, 119, 12041–12047.
   Web of Science ®Google Scholar
• Jia, Z.; O'Mara, M.L.; Zuegg, J.; Cooper, M.A.; Mark, A.E. Vancomycin: ligand recognition, dimerization and super-complex formation. FEBS J. 2013, 280, 1294–1307.
   PubMed Web of Science ®Google Scholar
• Treviño, J.; Bayón, C.; Ardá, A.; Marinelli, F.; Gandolfi, R.; Molinari, F.; Jimenez-Barbero, J.; Hernáiz, M.J. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy. Chemistry 2014, 20, 7363–7372.
   PubMed Web of Science ®Google Scholar
• Münch, D.; Engels, I.; Müller, A.; Reder-Christ, K.; Falkenstein-Paul, H.; Bierbaum, G.; Grein, F.; Bendas, G.; Sahl, H.-G.; Schneider, T. Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin. Antimicrob Agents Chemother. 2014, 59, 772–781.
   PubMed Web of Science ®Google Scholar